ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Funds and ETFs Alibaba Health Information Technology Limited
Equities
241
BMG0171K1018
Drug Retailers
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.2 HKD | +0.31% |
|
+4.92% | -24.53% |
| 04-03 | Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF | MT |
| 03-28 | Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement | CI |
ETFs positioned on Alibaba Health Information Technology Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 293 M€ | +16.81% | - | |
| 1.56% | 11 M€ | +17.78% | - | |
| 1.56% | 88 M€ | +19.31% | - | |
| 1.42% | 0 M€ | 0.00% | - | |
| 0.71% | 14 M€ | -3.17% | ||
| 0.69% | 2 M€ | +0.14% | ||
| 0.42% | 122 M€ | +16.54% | ||
| 0.22% | 10 M€ | +12.95% | - | |
| 0.16% | 4 M€ | -11.56% | ||
| 0.15% | 3 M€ | +6.68% | - | |
| 0.13% | 115 M€ | +2.02% | - | |
| 0.11% | 2 M€ | +24.97% | ||
| 0.04% | 112 M€ | +4.91% | - | |
| 0.04% | 4 M€ | -4.41% | - | |
| 0.04% | 2,867 M€ | +9.90% | - | |
| 0.04% | 153 M€ | +7.16% | - | |
| 0.04% | 454 M€ | +8.71% | - | |
| 0.04% | 7 M€ | -.--% | - | |
| 0.02% | 32 M€ | +8.03% | - | |
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 34 M€ | +3.53% | - | |
| 0.00% | 391 M€ | +8.75% | - | |
| 0.00% | 7 M€ | +5.65% | - | |
| 0.00% | 34 M€ | +8.28% | - |
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.963
CNY
Average target price
5.094
CNY
Spread / Average Target
+71.95%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.53% | 6.59B | |
| -29.72% | 15.83B | |
| -22.89% | 12.31B | |
| +15.23% | 6.45B | |
| -12.43% | 5.94B | |
| +0.73% | 4.66B | |
| +62.00% | 4.59B | |
| -5.94% | 3.96B | |
| -9.36% | 3.55B | |
| -6.71% | 3.06B |
- Stock Market
- Equities
- 241 Stock
- Funds and ETFs Alibaba Health Information Technology Limited